Darzalex Combination Approved in Europe for Some Newly Diagnosed Multiple Myeloma Patients
News
The European Commission has approved the anti-CD38 antibody Darzalex (daratumumab), in combination with standard therapy, for newly diagnosed multiple myeloma patients who cannot receive a stem cell transplant. The approval is ... Read more